Impulse control disorders could be accompanied by hypomanic state under intestinal levodopa infusion
Objective: To determine characteristics of parkinsonian patients under levodopa/carbidopa intestinal gel (LCIG) infusion who present impulse control disorders (ICDs). Background: ICDs may be induced by…Cerebral and pulmonary thromboembolism in a patient with hyperhomocystinemia treated with high dose levodopa/carbidopa intestinal gel
Objective: We report a case that developed cerebral and pulmonary thromboembolism during 24-hour levodopa/carbidopa intestinal gel (LCIG) infusion. Background: LCIG is a therapeutic option in…The hardest symptoms that bother patients with Parkinson’s disease before and 3 months after Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy
Objective: In this study we want to see what are the hardest and the most troublesome symptoms perceived by patients with Parkinson’s disease (PD) before…Integrated Complimentary Yoga and Ayurveda Treatment Confers Significant Benefits in PD Patients
Objective: The present study was carried out to evaluate the efficacy of integrated complimentary Yoga & Ayurveda treatment in improving the motor symptoms and also…Gait disorders in Parkinson’s disease: 19 observations at the University Hospital Center of Conakry
Objective: We report the cases in order to make a clinical and evolutionary evaluation of this pathology. Background: Gait disorders are more and more reported…Weight loss and nutritional status in Parkinson’s disease patients under levodopa/carbidopa intestinal gel infusion treatment
Objective: To investigate the occurrence of weight loss (WL) in Parkinson’s disease (PD) patients under LCIG treatment and to analyse its relationship with the nutritional…Clinical experiences in Whole systems Ayurveda Management of Parkinson’s Disease
Objective: PD Assessment of Ayurveda management using UPDRS -Motor, Hoehn & Yahr staging, Activity of Daily Living % (ADL). Background: Ayurveda holistic management comprises an…Sensory signs and neuropathic pain in advanced Parkinson’s disease under levodopa treatment
Objective: To evaluate whether patients affected by Parkinson’s disease (PD) under levodopa/carbidopa intestinal gel (LCIG) therapy have alterations in sensory symptoms and signs and/or painful…Combined Surgical Therapies for Optimal Management of Advanced Parkinson’s Disease
Objective: We report a case of a patient with advanced PD who began LCIG for refractory motor fluctuations while continuing longstanding STN-DBS. Background: LCIG and…Specific Bdnf variants are associated with suboptimal response to levodopa but not to other dopaminergic medications or deep brain stimulation in Parkinson’s disease
Objective: We examined the impact of rs6265 and other brain-derived neurotrophic factor (Bdnf) variants in two subject cohorts: 1) early-stage Parkinson’s disease (PD) subjects from…
- « Previous Page
- 1
- …
- 54
- 55
- 56
- 57
- 58
- …
- 70
- Next Page »